BlackRock Institutional Trust’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.1M Buy
381,679
+11,802
+3% +$61.6K ﹤0.01% 3035
2016
Q3
$1.85M Sell
369,877
-11,654
-3% -$54.8K ﹤0.01% 3084
2016
Q2
$1.72M Sell
381,531
-47,595
-11% -$218K ﹤0.01% 3094
2016
Q1
$1.93M Sell
429,126
-19,735
-4% -$94K ﹤0.01% 3061
2015
Q4
$2.36M Sell
448,861
-12,131
-3% -$69.1K ﹤0.01% 3054
2015
Q3
$2.66M Sell
460,992
-2,712
-0.6% -$16.9K ﹤0.01% 3006
2015
Q2
$3.31M Buy
463,704
+14,296
+3% +$99.4K ﹤0.01% 2910
2015
Q1
$2.99M Sell
449,408
-12,418
-3% -$77.5K ﹤0.01% 2943
2014
Q4
$2.76M Sell
461,826
-16,436
-3% -$84.4K ﹤0.01% 2970
2014
Q3
$2.36M Sell
478,262
-29,346
-6% -$142K ﹤0.01% 3005
2014
Q2
$2.28M Sell
507,608
-15,160
-3% -$67.7K ﹤0.01% 3132
2014
Q1
$2.35M Sell
522,768
-80,828
-13% -$384K ﹤0.01% 3099
2013
Q4
$3.08M Sell
603,596
-483,032
-44% -$2.36M ﹤0.01% 2987
2013
Q3
$4.92M Buy
1,086,628
+110,278
+11% +$549K ﹤0.01% 2741
2013
Q2
$4.99M Buy
+976,350
New +$4.86M ﹤0.01% 2706

Other funds holding CPIX

BlackRock Institutional Trust's CPIX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Cumberland Pharmaceuticals (CPIX) stake by 3.2% in Q4 2016, buying an estimated $61.6K and bringing the position to 381,679 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3035.

BlackRock Institutional Trust first reported a position in CPIX in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.99M in Q2 2013. 41 funds tracked by Wall St. Rank hold CPIX as of Q4 2016.

  • BlackRock Institutional Trust held 381,679 shares of Cumberland Pharmaceuticals worth $2.1M as of Q4 2016.
  • BlackRock Institutional Trust bought 11,802 Cumberland Pharmaceuticals shares in Q4 2016, an estimated $61.6K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3035 holding.
  • BlackRock Institutional Trust first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Cumberland Pharmaceuticals position peaked at $4.99M in Q2 2013.
  • 41 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.